Skip to main content
. 2021 Oct 5;2021:5093216. doi: 10.1155/2021/5093216

Table 2.

The effects of LA on renal I/R injury.

Species I/R models Treatments Effects and mechanisms Ref
Albino rats Both renal I/R (1 h/2 h) LA (100 mg/kg, i.p) at 2 days before I/R Attenuating histopathological injury via reducing oxidative damage [62]
Wistar albino rats Right nephrectomy and left renal I/R (45 min/24 h) LA (100 mg/kg, i.p) or saline twice, at 30 min before ischemia Inhibiting neutrophil infiltration and inflammation generation, balancing the oxidant-antioxidant status [63]
Sprague-Dawley rats Bilateral renal I/R (45 min/24 h) Pretreatment with LA (50 mg/kg i.p) for 2 weeks Decreasing levels of creatinine and urea together with oxidative stress and inflammation; elevating GSH levels and activities of antioxidant enzymes [64]
Albino Wistar rats Right nephrectomy and the left renal I/R (1 h/24 h) LA (100 mg/kg, i.p) 30 min before I/R Reducing degradation of extracellular matrix and oxidative stress via increasing matrix metalloproteinases-2 and -9 activities and decreasing metalloproteinases-1 and -2 levels [65]
Sprague-Dawley rats Bilateral renal I/R (40 min/2 d) LA (80 mg/kg i.p) at 48 and 24 h before ischemia and at 6 and 24 h after reperfusion Protecting renal function (e.g., aquaporins and sodium transporters) via normalizing activities of local arginine vasopressin/cAMP, nitric oxide/cGMP, and ET systems [66]
Sprague-Dawley rats Right nephrectomy and left renal I/R (45 min/24 h) LA (10 or 100 mg/kg, i.p) at 24 and 1 h before ischemia Attenuating the deterioration of renal function; repressing tubular necrosis, proteinaceous casts in tubuli, and medullary congestion through suppressing ET-1 [67]